Navigation Links
MiStent SES erweist sich im klinischen Umfeld als einzigartig
Date:10/28/2013

the Native Coronary Arteries)" erschienen ist. Zu den Autoren des Artikels zählten die Co-Forschungsleiter der Studie DESSOLVE I – Dr. med. William Wijns, Ph.D., vom Herz- und Gefäßzentrum im belgischen Aalst und John Ormiston, M.B.Ch.B., von der Mercy Angiography Unit in Auckland (Neuseeland).

Informationen zum MiStent SES

Das MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES®) wurde zur Optimierung des Heilungsverlaufs von Patienten mit koronarer Herzkrankheit konzipiert. Die schnell absorbierbare Beschichtung des MiStent SES soll die Wirkstofffreisetzung präzise und beständig steuern und die Dauer der Polymerexposition beschränken, um so die Sicherheitsrisiken in Verbindung mit derzeit erhältlichen Medikamente freisetzenden Stent-Technologien zu reduzieren.

Das innovative MiStent SES-System umfasst eine firmeneigene Stent-Beschichtung mit einem kristallinen Wirkstoff (Sirolimus) und einem absorbierbaren Polymer. Mit der Aufweichung des Polymers und seiner Absonderung aus dem Stent in angrenzendes Gewebe ermöglicht die Beschichtung eine kontrollierte und nachhaltige Freisetzung therapeutischer Wirkstoffmengen. Mit diesen Eigenschaften soll die Sicherheit im Vergleich zu konventionellen permanenten Polymer-DES gezielt erhöht werden.

Unter Verwendung eines zugelassenen Medikaments (Sirolimus) und Polymers (PLGA) macht es die patentierte superkritische Fluidtechnologie von Micell möglich, reine Metall-Stents mit streng kontrollierten Wirkstoff- und Polymerbeschichtungen zu überziehen. Das MiStent SES macht sich die Vorteile des hochmodernen Genius® MAGIC Cobalt Chromium Coronary Stent System von Eurocor (mit CE-Zulassung) zunutze, bei dem es sich um einen reinen Metall-Stent mit nachweislich hervorragender Einsetzbarkeit, Konformität und Flexibilität handelt.

Versuche
'/>"/>

SOURCE Micell Technologies
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. MiStent SES Shown to be Unique in Clinical Setting
2. Micell Technologies Announces Development and Distribution Agreement to Bring MiStent SES to China
3. Micell Technologies Receives CE Mark Approval for MiStent SES
4. Pfizer zeichnet die südafrikanischen, klinischen Forschungsstandorte von Synexus INSPIRE Standorte aus - als erste in Afrika
5. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
6. Filtrona Porous Technologies präsentiert neue medizinische Schäume und einzigartige Faserprodukte für saubere Arbeitsumgebungen auf MEDICA / COMPAMED-Messe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- Research and Markets  has announced the addition ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... monitor, and assess medical conditions, diseases, or infections usually ... earlier and more targeted treatment. These tests are minimally ... This kind of diagnostics provides early detection of diseases ...
(Date:7/22/2014)... , July 22, 2014 BiologicTx ® ... first 3-way Kidney Paired Donation transplant exchange ... procedures happened on July 9 at the Miami Transplant ... Miami, Fla. Kidney Paired ... are not compatible for kidney transplant with one another ...
(Date:7/22/2014)... , July 22, 2014  A central ... a SynCardia temporary Total Artificial Heart ... Strong Memorial Hospital with the Freedom® portable driver ... Fontana, a 64-year-old retiree from a Syracuse ... He managed the condition with medications, an implantable ...
Breaking Medicine Technology:Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... Calif., Feb. 24, 2011 Codexis, Inc. (Nasdaq: ... promoted to Chief Technology Officer and Senior Vice President, Process ... report to Alan Shaw, Ph.D., President and Chief Executive Officer. ... a 25-year career with DuPont. He served as Vice President, ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... ended December 31, 2010. For the fourth quarter ... $227 million and income from continuing operations of $17.6 million, ... million charge related to the settlement of litigation and changes ...
Cached Medicine Technology:Codexis Names David Anton CTO & SVP, Process Development & Manufacturing 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 3Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 4Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 5Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 6Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 7Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 8Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 9Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 10
(Date:7/22/2014)... (Boston)-- Researchers from Boston University School of Medicine ... that participants who received care through BMC,s Violence ... physical, mental, emotional and social needs of violently ... injuries and experienced life changing behaviors through connections ... feel trust and hope. These findings are reported ...
(Date:7/22/2014)... July 22, 2014 BlogHer, Inc. ... women, this year celebrates its tenth anniversary where it ... of attendees, including community leaders from the new women’s ... every consumer vertical, will converge in San Jose this ... and a “selfiebration” of social technology. , BlogHer’s ...
(Date:7/22/2014)... 22, 2014 New study findings released ... New Jersey’s patient-centered program is working to improve the ... study is the largest to date and includes more ... innovative approach that focuses on delivering better quality outcomes, ... care. , “Our most recent study results clearly ...
(Date:7/22/2014)... study by HIV researchers from Aarhus University and Aarhus ... drug can activate hidden HIV. The researchers found that ... HIV-infected cells between 2.1 and 3.9 times above normal ... to measurable levels in five out of six patients ... The results were presented today as breaking news at ...
(Date:7/22/2014)... CyraCom has been ranked as North America’s ... and interpreting industry. Released June 2014 by the market ... Language Services Market: 2014," also ranked CyraCom as the ... two spots from 2013. , In 2013, Common Sense ... interpretation services – a subset of the language service ...
Breaking Medicine News(10 mins):Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 2Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 3Health News:Anti-cancer drug kicks HIV out of hiding 2Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2
... turning their backs on tanning amid growing concerns over skin ... survey shows that teenagers are resisting the urge to tan ... 5,073 Australian adults and 699 Australian teenagers aged 12 to ... that 68 % of those aged 12-17 said they had ...
... University have found a new model that shows how ... in the presence of microenvironment of tumor cells. // ... skin cell to malignant cell is understood with the ... offer new insights into the influence of the tumor ...
... the developing fetus, a womb confers safety and security to ... a womb is even necessary for normal brain development. // ... found to have a poor brain development when compared to ... done regarding brain development of babies born around 26 weeks ...
... bottle-feeding may impose an increased risk of iron deficiency ... American children) according to // a new study by ... Wisconsin. , ,"This is the first study that ... prolonged bottle-feeding and iron deficiency, among a nationally representative ...
... in the UK has revealed that smokers are unconcerned with ... particular they seemed to be aware of the damage // ... lip and even the teeth, but were strangely reluctant to ... oral and maxillofacial surgeons, who are launching a massive awareness ...
... across the walls of a patient's room have been ... hypertension and rheumatic complaints, a study says.//,A study group ... kept in medicated rooms were cured in shorter less ... study involved 36 patients, of whom 19 were kept ...
Cached Medicine News:Health News:Aussie teens applauded for declining sun tan 2Health News:New Model for understanding Tumor Metastasis 2Health News:Brain development compromised in premature babies 2Health News:Iron deficiency found in children with prolonged bottle feeding 2Health News:Now medicated coir to cure ailments 2
Agarose L03 is recommended for separations of DNA fragments = 1,000 bp....
... Anion traces: chloride (Cl) ≤ 5000 mg/kg sulfate (SO ... 50 mg/kg Cd ≤ 5 mg/kg Co ≤ 5 ... Fe ≤ 10 mg/kg K ≤ 50 mg/kg Mg ... 2000 mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... flexible gels for separation of ... of wide range and standard ... mg/mL, clear, faintly yellow, hot ... MP: 90 °C (1% in ...
Medicine Products: